Literature DB >> 8425220

Oncogenic activity of the c-Myc protein requires dimerization with Max.

B Amati1, M W Brooks, N Levy, T D Littlewood, G I Evan, H Land.   

Abstract

c-Myc (Myc) and Max proteins dimerize and bind DNA through basic-helix-loop-helix-leucine zipper motifs (b-HLH-LZ). Using a genetic approach, we demonstrate that binding to Max is essential for Myc transforming activity and that Myc homodimers are inactive. Mutants of Myc and Max that bind efficiently to each other but not to their wild-type partners were generated by either exchanging the HLH-LZ domains or reciprocally modifying LZ dimerization specificities. While transformation defective on their own, complementary mutants restore Myc transforming activity when coexpressed in cells. The HLH-LZ exchange mutants also have dominant negative activity on wild-type Myc function. In addition, wild-type max antagonizes myc function in a dose-dependent manner, presumably through competition of Max-Max and Myc-Max dimers for common target DNA sites. Therefore, Max can function as both suppressor and activator of Myc. A general model for the role of Myc and Max in growth control is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425220     DOI: 10.1016/0092-8674(93)90663-b

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  176 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Essential role for Max in early embryonic growth and development.

Authors:  H Shen-Li; R C O'Hagan; H Hou; J W Horner; H W Lee; R A DePinho
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

4.  BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation.

Authors:  Jeonghyeon Park; Marcelo A Wood; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.

Authors:  Kyle Lafferty-Whyte; Alan Bilsland; Stacey F Hoare; Sharon Burns; Nadia Zaffaroni; Claire J Cairney; William Nicol Keith
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

6.  Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max.

Authors:  K M Ryan; G D Birnie
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

7.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation.

Authors:  B A Malynn; I M de Alboran; R C O'Hagan; R Bronson; L Davidson; R A DePinho; F W Alt
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

Review 8.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

9.  Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.

Authors:  Asya V Grinberg; Chang-Deng Hu; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner.

Authors:  W R Atchley; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.